MEDIAN Technologies names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

Sophia Antipolis, France

MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America.  Ciaran Cooper will be responsible for developing the company’s US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years’ experience in medical imaging with an emphasis in business development, strategic planning, and team management.  Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET.  He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

I’m very excited to join MEDIAN at this time in their development,” said Ciaran Cooper. MEDIAN’s LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials.  I look forward to carrying our message to market.

“We’re thrilled to welcome Ciaran to our team,” said Jerome Windsor, VP Business Development at MEDIAN Technologies. “Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company.”

Download C-Cooper-at-Median.pdf